Article info

Download PDFPDF
Cholinesterase inhibitor use does not significantly influence the ability of 123I-FP-CIT imaging to distinguish Alzheimer’s disease from dementia with Lewy bodies
  1. Dr John-Paul Taylor, Institute for Ageing and Health, Wolfson Research Centre, Newcastle General Hospital, Westgate Road, Newcastle upon Tyne NE4 6BE, UK; john-paul.taylor{at}ncl.ac.uk
View Full Text

Citation

Taylor J, Colloby SJ, McKeith IG, et al
Cholinesterase inhibitor use does not significantly influence the ability of 123I-FP-CIT imaging to distinguish Alzheimer’s disease from dementia with Lewy bodies

Publication history

  • Received November 21, 2006
  • Accepted January 26, 2007
  • Final version accepted February 5, 2007
  • First published February 13, 2007.
Online issue publication 
September 18, 2007

Article Versions

Request permissions

If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.